Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy

por Lingvay, Ildiko, Greenberg, Michelle, Gallo, Silvina, Shi, Harry, Liu, Jie, Gantz, Ira
Publicado 2021

51 Relationship of Early Dressing Change, Ambulation, and Early Discharge in Lower Extremity Grafted Burn Wounds

por Toledo, Sandor, Blome-Eberwein, Sigrid, Barros De Souza, Cesar, Shi, Harry, Watanabe, Miname, Anderson, Morgan
Publicado 2023

Outcomes of pediatric thyroidectomy: a cross-sectional evaluation

por Azari, Sarah, Randolph, Jackson, Shi, Harry, Hoover, Travis, Weaver, Daniel, Mattioni, Jillian, Chennupati, Sri Kiran
Publicado 2020

Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate:...

por Takeuchi, Tsutomu, Fleischmann, Roy, Iikuni, Noriko, Shi, Harry, Soma, Koshika, Paulissen, Jerome, Hirose, Tomohiro, Smolen, Josef S.
Publicado 2021

Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate

por Fleischmann, Roy, Haraoui, Boulos, Buch, Maya H., Gold, David, Sawyerr, Gosford, Shi, Harry, Diehl, Annette, Lee, Kristen
Publicado 2022

Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?

por Deanfield, John E., Sellier, Phillipe, Thaulow, Erik, Bultas, Jan, Yunis, Carla, Shi, Harry, Buch, Jan, Beckerman, Bruce
Publicado 2010

Long‐term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104‐week VERTIS MET trial

por Gallo, Silvina, Charbonnel, Bernard, Goldman, Allison, Shi, Harry, Huyck, Susan, Darekar, Amanda, Lauring, Brett, Terra, Steven G.
Publicado 2019

Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitin...

por Strand, Vibeke, Kaine, Jeffrey, Alten, Rieke, Wallenstein, Gene, Diehl, Annette, Shi, Harry, Germino, Rebecca, Murray, Christopher W.
Publicado 2020

Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV

por Dagogo-Jack, Samuel, Frederich, Robert, Liu, Jie, Cannon, Christopher P, Shi, Harry, Cherney, David Z I, Cosentino, Francesco, Masiukiewicz, Urszula, Gantz, Ira, Pratley, Richard E
Publicado 2023

Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA...

por Winthrop, Kevin L, Citera, Gustavo, Gold, David, Henrohn, Dan, Connell, Carol A, Shapiro, Andrea B, Shi, Harry, Onofrei, Alina M, Pappas, Dimitrios A, Schulze-Koops, Hendrik
Publicado 2021

Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b...

por Cohen, Stanley B, Pope, Janet, Haraoui, Boulos, Mysler, Eduardo, Diehl, Annette, Lukic, Tatjana, Liu, Shixue, Stockert, Lori, Germino, Rebecca, Menon, Sujatha, Shi, Harry, Keystone, Edward C
Publicado 2021

Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies

por Dikranian, Ara H, Gonzalez-Gay, Miguel A, Wellborne, Frank, Álvaro-Gracia, José María, Takiya, Liza, Stockert, Lori, Paulissen, Jerome, Shi, Harry, Tatulych, Svitlana, Curtis, Jeffrey R
Publicado 2022